# Limited Competition: Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed)

Source: https://welltoldgrants.com/grants/par-24-105-limited-competition-mutant-mouse-resource-and-research/  
Official notice: https://www.grants.gov/search-results-detail/351684

> National Institutes of Health offered grants to small businesses. Applications closed on September 1, 2024.

| Field | Value |
|---|---|
| Opportunity number | PAR-24-105 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | September 1, 2024 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.351 |

## Who can apply

- Small businesses

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. See full Notice of Funding Opportunity for additional details on eligibility.

## What the grant funds

This Notice of Funding Opportunity (NOFO) invites applications for the continued support and advancement of the Mutant Mouse Resource and Research Centers (MMRRC). The MMRRC consortium is expected to facilitate research by identifying, acquiring, evaluating, characterizing, cryopreserving, and distributing mutant mouse strains to qualified biomedical investigators. A regional network of four MMRRCs and an Informatics, Coordination and Service Center (ICSC) collectively serve the needs of the biomedical research community for transgenic, knockout and other genetically-engineered mutant mice and related biomaterials. MMRRC strains are held to the highest standards to optimize reproducibility of studies and assure scientific rigor and transparency; all submitted strains are thoroughly reviewed and documented and include additional quality control measures. The Program Director/Principal Investigator (PD/PI) of each MMRRC in addition to the major resource activities is required to develop a small high risk, high return, research pilot project that complements the goals and needs of the MMRRC consortium.

## Questions people ask

### Is PAR-24-105 still open?

No. It closed on September 1, 2024.

### Who can apply for Limited Competition: Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed)?

National Institutes of Health accepted applications from small businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Limited Competition: Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed)?

Closed September 1, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### Who has been funded under PAR-24-105?

NIH RePORTER lists 4 projects funded under PAR-24-105 in fiscal 2025 to 2026, at 4 institutions. The most were at University of California at Davis, Jackson Laboratory, University of Missouri-Columbia.

### Who has won Research Infrastructure Programs grants before?

The largest recipients over five fiscal years were University of California, Davis, Oregon Health & Science University, University of Washington. The program made 1,102 awards worth $1.4 billion in that time.